Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
World Science and Technology-Modernization of Traditional Chinese Medicine ; (12): 1209-1213, 2017.
Article in Chinese | WPRIM | ID: wpr-696001

ABSTRACT

This study was aimed to analyze the pathogen distribution,drug resistance and traditional Chinese medicine (TCM) syndrome of patients with primary nephrotic syndrome complicated with pulmonary infection for the guidance of clinical practice.The clinical data of 180 patients with primary nephrotic syndrome complicated with pulmonary infection were analyzed.The results showed that among 180 patients,117 were male,accounting for 65%;73.33% of them were over 40 years old.Membranous nephropathy was the most common pathological type,accounting for 40%.Gram-negative bacteria were the main pathogen,accounting for 51.72%.The drug resistance rates of piperacillin/tazobactam,imipenem,amikacin,gentamicin were the lowest.The drug resistance rates of third generation of cephalosporins and quinolone antibiotics were in the middle.In TCM syndrome differentiation,central qi deficiency and phlegm syndrome occupied the highest proportion,accounting for 25.56%;and the phlegm heat in the lung syndrome,accounting for 17.78%;wind evil attacking the lung syndrome,accounting for 13.33%;qi deficiency and phlegm syndrome,accounting for 9.45%;qi deficiency,blood stasis and water stagnation syndrome,accounting for 8.89%;the mixture of deficiency and excess syndrome,accounting for 59.45%,with qi deficiency as the main part.It was concluded that middle-aged and older men,pathologic type of membranous nephropathy had the higher rate of suffering pulmonary infection.Gram-negative bacteria were the main pathogen.The choice of antibiotics should be based on piperacillin/tazobactam,and third generation of cephalosporins.Qi deficiency and phlegm syndrome was the most common TCM syndrome.

2.
Chongqing Medicine ; (36): 3357-3359, 2015.
Article in Chinese | WPRIM | ID: wpr-477133

ABSTRACT

Objective To evaluate the clinical efficacy and safety of capecitabine continuous maintenance in treatment of re-currence of triple-negative breast cancer,which had responded to combined chemoradiotherapy.Methods The triple-negative breast cancer was defined as negative of ER,PR and HER2.A total of 46 patients of triple-negative breast cancer were divided into the treatment group (23 patients)and the control group (23 patients).The treatment group was given capecitabine continuous mainte-nance after 6 cycles of chemotherapy.The control group was given 6 cycles of combined chemotherapy only.The clinical efficacy and safety was evaluated between the two groups.Results The PR,PD,RR,and DCR in the treatment group were significantly higher than those in the control group(P 0.05).Conclusion Capecitabine continuous maintenance after combined chemoradiotherapy in treatment of recurrence of triple-neg-ative breast cancer is more effective,lower toxicity and tolerable.

SELECTION OF CITATIONS
SEARCH DETAIL